After silencing VDAC1 expression in cancer cells for an extended period of 10–15 days, significant reductions in glioblastoma cancer stem cell (GSC) markers were observed, accompanied by morphological changes indicative of differentiation into more mature, normal-like cells [74,94]. The gene discussed is VDAC1; the disease is cancer.